CompletedNCT00194129
Lithium with divalproex for rapid-cycling bipolarity and substance use
About this title
Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
Read the official source — NCT00194129Medication studyAges 16–65United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 16 years to 65 years. Other eligibility criteria applied.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNovember 1997
- Recruitment status
- Completed
- Enrollment listed in the registry
- 31
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 16 Years to 65 Years
- Official registry ID
- NCT00194129
- Official title
Show the full official title
A Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including lithium, Divalproex and Placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 16 years to 65 years. Other eligibility criteria applied.
